Request Demo
Last update 27 Feb 2025
ATX-295
Last update 27 Feb 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms ATX-295 |
Target |
Mechanism KIF18A modulators(kinesin family member 18A modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization  Accent Therapeutics, Inc.Startup |
Active Organization Accent Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with ATX-295NCT06799065
A Phase 1/2, Open-Label, Dose-Escalation and Expansion First-In-Human Study of ATX-295, an Oral Inhibitor of the Kinesin Motor Protein KIF18A, in Patients With Locally Advanced or Metastatic Solid Tumors, Including High-Grade Serous Ovarian Cancer
100 Clinical Results associated with ATX-295
Login to view more data
100 Translational Medicine associated with ATX-295
Login to view more data
100 Patents (Medical) associated with ATX-295
Login to view more data
100 Deals associated with ATX-295
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | - | Accent Therapeutics, Inc.Startup | 30 Apr 2025 |
| Breast cancer recurrent | Phase 1 | - | Accent Therapeutics, Inc.Startup | 30 Apr 2025 |
| Ovarian Serous Tumor | Phase 1 | - | Accent Therapeutics, Inc.Startup | 30 Apr 2025 |
| Triple Negative Breast Cancer | Phase 1 | - | Accent Therapeutics, Inc.Startup | 30 Apr 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free